Rob Adelman, M.D., Private Equity Partner. Dr. Adelman joined OrbiMed in 2002 to focus on private equity investments and structured transactions of small-capitalization public equity companies. Prior to joining OrbiMed, Dr. Adelman was Vice President of Business Development at NeoGenesis Pharmaceuticals. Prior to his tenure with NeoGenesis, he was a founder of Veritas Medicine. He was also a co-founder of Operon Technology, one of the largest commercial producers of synthetic DNA in the world. He trained as an orthopedic surgeon at the Hospital for Special Surgery at Cornell University. As a practicing orthopedic surgeon, he was involved with major implant manufacturers on hip and knee replacement design. Dr. Adelman received his B.A. with the highest honors from the University of California, Berkeley and his M.D. from Yale University School of Medicine. Dr. Adelman serves on the Boards of Volcano Corporation, CryoCor Inc, Sientra Inc., Aryx Inc, Innovative Spinal Technologies Inc, and Cerimon Pharmaceuticals.
Back to Top